Key Points
- EVP Leann Smith sold 190 shares of McKesson on Feb. 17 at an average price of $945 for proceeds of $179,550, reducing her holding to 2,989 shares (a 5.98% drop) as disclosed in an SEC Form 4 filing.
- McKesson beat quarterly estimates with EPS of $9.34 and revenue of $106.16 billion (up 11.4% YoY), and has set FY2026 guidance of $38.80–$39.20 EPS while analysts show a consensus target near $943.50 and a majority of Buy ratings.
- Company payout and size metrics: McKesson declared a $0.82 quarterly dividend (payable April 1, ex‑dividend March 2) equating to a $3.28 annualized payout and ~0.3% yield, with a market cap around $115.9 billion and a P/E of ~27.2.
McKesson Corporation (NYSE:MCK - Get Free Report) EVP Leann Smith sold 190 shares of the business's stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the sale, the executive vice president directly owned 2,989 shares of the company's stock, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
McKesson Price Performance
MCK opened at $946.52 on Thursday. The stock's 50 day simple moving average is $848.54 and its 200 day simple moving average is $793.10. The firm has a market cap of $115.94 billion, a price-to-earnings ratio of 27.22, a PEG ratio of 1.52 and a beta of 0.40. McKesson Corporation has a 1 year low of $594.34 and a 1 year high of $971.93.
McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion for the quarter, compared to analysts' expectations of $105.98 billion. During the same quarter last year, the business earned $8.03 earnings per share. The business's revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, sell-side analysts anticipate that McKesson Corporation will post 32.77 EPS for the current year.
McKesson Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. McKesson's dividend payout ratio (DPR) is presently 9.43%.
Wall Street Analyst Weigh In
MCK has been the subject of several research analyst reports. Evercore reiterated an "outperform" rating and issued a $1,000.00 price objective on shares of McKesson in a report on Thursday, November 6th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of McKesson in a report on Wednesday, December 10th. Weiss Ratings lowered shares of McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a report on Thursday, February 5th. TD Cowen raised their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a "buy" rating in a research report on Thursday, February 5th. Finally, UBS Group increased their price target on shares of McKesson from $920.00 to $980.00 and gave the stock a "buy" rating in a research note on Thursday, November 6th. Thirteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, McKesson has an average rating of "Moderate Buy" and a consensus target price of $943.50.
Read Our Latest Research Report on MCK
Institutional Trading of McKesson
A number of hedge funds and other institutional investors have recently modified their holdings of MCK. Brighton Jones LLC boosted its stake in McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company's stock worth $1,438,000 after acquiring an additional 798 shares in the last quarter. Caxton Associates LLP purchased a new stake in shares of McKesson in the first quarter worth $233,000. Sivia Capital Partners LLC increased its holdings in shares of McKesson by 77.9% during the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company's stock valued at $502,000 after acquiring an additional 300 shares in the last quarter. Stratos Wealth Partners LTD. raised its position in shares of McKesson by 4.2% in the 2nd quarter. Stratos Wealth Partners LTD. now owns 2,105 shares of the company's stock worth $1,543,000 after purchasing an additional 85 shares during the last quarter. Finally, Chicago Partners Investment Group LLC increased its stake in McKesson by 16.3% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 1,069 shares of the company's stock valued at $763,000 after purchasing an additional 150 shares in the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.
About McKesson
(
Get Free Report)
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
